XIO acquires Lumenis for approximately $510 million, $14 per share, in cash
Clients XIO Group
Jones Day advised XIO Group in its acquisition of Lumenis Ltd., the world's largest energy-based medical company for surgical, ophthalmology, and aesthetic applications, for $14 per share in cash, for an aggregate purchase price of approximately $510 million. Jones Day also assisted with the financing which consisted of a term loan, revolving loan, and a bridge loan provided by Mizrahi Tehafot Bank Ltd. ZELPEL acted as lead counsel with respect to the Israel law facility agreement.
In addition to M&A representation, Jones Day provided intellectual property and health care advice regarding this transaction.